BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2713508)

  • 41. Effects of recombinant human G-CSF, GM-CSF, IL-3, and IL-1 alpha on the growth of purified human peripheral blood progenitors.
    Takaue Y; Kawano Y; Reading CL; Watanabe T; Abe T; Ninomiya T; Shimizu E; Ogura T; Kuroda Y; Yokobayashi A
    Blood; 1990 Jul; 76(2):330-5. PubMed ID: 1695111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures.
    Lokhorst HM; Lamme T; de Smet M; Klein S; de Weger RA; van Oers R; Bloem AC
    Blood; 1994 Oct; 84(7):2269-77. PubMed ID: 7919345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.
    Bataille R; Barlogie B; Lu ZY; Rossi JF; Lavabre-Bertrand T; Beck T; Wijdenes J; Brochier J; Klein B
    Blood; 1995 Jul; 86(2):685-91. PubMed ID: 7605999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop.
    Gu ZJ; Costes V; Lu ZY; Zhang XG; Pitard V; Moreau JF; Bataille R; Wijdenes J; Rossi JF; Klein B
    Blood; 1996 Nov; 88(10):3972-86. PubMed ID: 8916964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?
    Kovacs E
    Leuk Res; 2010 Jul; 34(7):912-6. PubMed ID: 19762082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation.
    Borset M; Helseth E; Naume B; Waage A
    Br J Haematol; 1993 Nov; 85(3):446-51. PubMed ID: 8136264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a new human plasma cell leukemia cell line UHKT-944.
    Vyhlídalová I; Uherková L; Pleschnerová M; Špička I; Březinová J; Michalová K; Čermáková K; Polanská V; Jedelský PL; Hamšíková E; Kuželová K; Stöckbauer P
    Eur J Haematol; 2015 Oct; 95(4):352-60. PubMed ID: 25600340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF.
    McNiece I; Andrews R; Stewart M; Clark S; Boone T; Quesenberry P
    Blood; 1989 Jul; 74(1):110-4. PubMed ID: 2473792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
    Janowska-Wieczorek A; Marquez LA; Nabholtz JM; Cabuhat ML; Montaño J; Chang H; Rozmus J; Russell JA; Edwards DR; Turner AR
    Blood; 1999 May; 93(10):3379-90. PubMed ID: 10233890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.
    Klein B; Zhang XG; Jourdan M; Content J; Houssiau F; Aarden L; Piechaczyk M; Bataille R
    Blood; 1989 Feb; 73(2):517-26. PubMed ID: 2783861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF.
    Caracciolo D; Clark SC; Rovera G
    Blood; 1989 Feb; 73(3):666-70. PubMed ID: 2644983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
    Lemoli RM; Fortuna A; Motta MR; Rizzi S; Giudice V; Nannetti A; Martinelli G; Cavo M; Amabile M; Mangianti S; Fogli M; Conte R; Tura S
    Blood; 1996 Feb; 87(4):1625-34. PubMed ID: 8608257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells.
    Urashima M; Ogata A; Chauhan D; Hatziyanni M; Vidriales MB; Dedera DA; Schlossman RL; Anderson KC
    Blood; 1996 Mar; 87(5):1928-38. PubMed ID: 8634441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells.
    Barker HF; Hamilton MS; Ball J; Drew M; Franklin IM
    Br J Haematol; 1992 Jul; 81(3):331-5. PubMed ID: 1382543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture.
    Coutinho LH; Will A; Radford J; Schiró R; Testa NG; Dexter TM
    Blood; 1990 Jun; 75(11):2118-29. PubMed ID: 1693295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro.
    Portier M; Zhang XG; Caron E; Lu ZY; Bataille R; Klein B
    Blood; 1993 Jun; 81(11):3076-82. PubMed ID: 8499642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishment of a human myeloma cell line with growth-promoting activity for bone marrow-derived fibroblastoid colony-forming cells.
    Takahira H; Kozuru M; Hirata J; Obama K; Uike N; Iguchi H; Miyamura T; Yamashita S; Kono A; Umemura T
    Exp Hematol; 1994 Mar; 22(3):261-6. PubMed ID: 8112425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis.
    Frassanito MA; Cusmai A; Iodice G; Dammacco F
    Blood; 2001 Jan; 97(2):483-9. PubMed ID: 11154226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow.
    King MA; Nelson DS
    Blood; 1989 May; 73(7):1925-35. PubMed ID: 2785420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.